Chemical and Enzymatic Oxidation of Furosemide: Formation of Pyridinium Salts

Ling-Jen Chen* and Leo T. Burka
Laboratory of Pharmacology and Chemistry, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709
Chem. Res. Toxicol., 2007, 20 (12), pp 1741–1744
DOI: 10.1021/tx700262z
Publication Date (Web): October 4, 2007
Copyright This article not subject to U.S. Copyright. Published 2007 by the American Chemical Society
* To whom correspondence should be addressed. Present address: Lovelace Respiratory Research Institute, 2425 Ridgecrest Drive SE, Albuquerque, New Mexico 87108. Tel: 505-348-9735 . Fax: 505-348-4980. E-mail: ljferguson@lrri.org.

Abstract

Abstract Image

Furosemide (Lasix) is frequently used in the treatment of cardiovascular and renal disease. Only one metabolite, furosemide glucuronide, has ever been identified. Oxidation of furosemide by cytochrome P450 has been demonstrated, but the metabolite(s) has never been identified. The oxidation of furosemide by dimethyldioxirane in acetone and by liver microsomal incubations was explored in this study. The first observable product from dimethyldioxirane oxidation was a ring-expanded enone resulting from an intramolecular condensation of the aldehyde group of the enonal, the secondary amine, and the carboxylic acid in a Mannich-like reaction. Keto–enol tautomerization and opening of the lactone gave a stable pyridinium salt. The pyridinium salt was also observed in the microsomal incubations of furosemide. The presence of an internal nucleophile in furosemide may have a significant effect on the toxicology and possibly the pharmacology of this furan.

Tools

History

  • Published In Issue December 17, 2007
  • Article ASAPOctober 04, 2007
  • Received: July 23, 2007
    Accepted:  ,
    Revised:  ,

Recommend & Share

Related Content

Other ACS content by these authors: